![OB GYN new masthead 1](https://prodcraftsa01.blob.core.windows.net/assets/products/ob-gyn-clinical-alert/_contentImage/OB_GYN_new_masthead_1.png)
OB/GYN Clinical Alert – August 1, 2024
August 1, 2024
View Issues
-
Maternal Mortality in the United States Is Worse than in any Other High-Income Nation
This article compares U.S. maternal mortality to other nations and explores reasons why mortality in the United States is four to 10 times higher than in peer countries.
-
How Common Is Cardiovascular Disease in Pregnant and Postpartum Women from Socioeconomically Disadvantaged Backgrounds?
Neighborhood-level socioeconomic inequities in early pregnancy were associated with higher risk of long-term cardiovascular disease in pregnant and postpartum women.
-
Comparing Medications Used for Lactation Inhibition
A randomized controlled trial demonstrated superior efficacy of cabergoline compared to pyridoxine (78% vs. 35%; P < 0.001) at suppression of lactation seven days after delivery.
-
A Review of HIV Pre-Exposure Prophylaxis
Knowing one’s human immunodeficiency virus (HIV) status can help patients take steps to prevent transmission. Male and female condoms are options for preventing HIV during sexual intercourse. These products are widely available over the counter in retail stores and pharmacies and their use should be encouraged for preventing sexually transmitted infections. Yet, there is another option available, pre-exposure prophylaxis (PrEP), for patients to prevent HIV that many providers have not yet added to their armamentarium. This special feature will review the indications for PrEP, its use, and the medications recommended.